Global Insulin Infusion Pumps Market Size, Share, and COVID-19 Impact Analysis By Type (Patch, Tethered), By Accessories (Insulin Reservoir Or Cartridges, Insulin Set Insertion Devices, Battery), By End-use (Hospitals and Clinics, Homecare, Laboratories), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030

Industry: Healthcare

RELEASE DATE Mar 2023
REPORT ID SI1619
PAGES 200
REPORT FORMAT PathSoft

Global Insulin Infusion Pumps Market Insights Forecasts to 2030

  • The Insulin Infusion Pumps Market Size was valued at USD 4.2 Billion in 2021.
  • The Market is growing at a CAGR of 8.5% from 2022 to 2030
  • The Worldwide Insulin Infusion Pumps Market is expected to reach USD 7.9 Billion by 2030
  • Asia Pacific is expected to Grow the fastest during the forecast period

Global Insulin Infusion Pumps Market

Get more details on this report -

Request Free Sample PDF

The Global Insulin Infusion Pumps Market is expected to reach USD 7.9 Billion by 2030, at a CAGR of 8.5% during the forecast period 2022 to 2030.

The implantable insulin pump is basically a pump which is implanted surgically under the catheter and skin from the insulin and extended into the peritoneal cavity. The peritoneal cavity consists lots of blood vessels and hence, the absorption of insulin is great in this cavity. These insulin pumps functions on the basis of blood glucose concentration. This means if the blood glucose level is less, the concentration of insulin released is lesser. On the other hand, if the blood glucose level is higher, the concentration of insulin released will also be higher. The introduction of healthcare technologies have mentioned the requirement of high quality diagnosis than the current insulin supply because it lessen the diabetes based stress, removes the requirement of insulin supplements, decreases the requirement of regular blood tests, as well as maintains the carbohydrate counting.

 

Impact of COVID 19 on Global Insulin Infusion Pumps Market

The COVID 19 pandemic has impacted the global insulin infusion pumps market positively. The pandemic has resulted more than 100 million cases of infection as well as over 2 million deaths across the world. The uncontrolled hyperglycemia and diabetes are the major factors for the people who are infected due to COVID 19 along with the severe illness and death. Diabetic people have weak immune system and the COVID 19 virus worsens the health condition of the patient which is why the immune system gets weaker faster. The companies which are engaged in making insulin infusion pumps have made sure to deliver insulin delivery devices to the patients on time through the help of local governments.

 

Global Insulin Infusion Pumps Market Report Coverage

Report CoverageDetails
Base Year:2021
Market Size in 2021:USD 4.2 Billion
Forecast Period:2021-2030
Forecast Period CAGR 2021-2030 :8.5%
2030 Value Projection:USD 7.9 Billion
Historical Data for:2017-2020
No. of Pages:200
Tables, Charts & Figures:130
Segments covered:By Type, By Accessories, By End-use, By Region, and COVID-19 Impact Analysis
Companies covered::Hoffman-La Roche Ltd., Tandem Diabetic Care, Inc., Medtronic plc, Sooil Development, Insulet Corporation, JingasuDelfu Co., Ltd., Valeritas, Inc., Ypsomed
Pitfalls & Challenges:COVID-19 has the potential to impact the global market

Get more details on this report -

Request Free Sample PDF
 

    

Key Market Drivers

Increasing demand for ambulatory infusion pumps in home care settings and rising cases of chronic diseases is driving the market

Infusion pumps like insulin pumps, implantable pumps, as well as ambulatory chemotherapy pumps are extensively used in home care settings to manage various diseases, including cancer as well as diabetes. Ambulatory infusion pumps are mainly developed to be wearable and portable. Infusion pumps are widely used for delivering fluids like medicines, nutrients, and antibiotics into the body of the patients in home settings, ambulatory surgery centers, hospitals, long term care facilities, and infusion clinics. Over the last few years, the demand for home healthcare has witnessed significant growth due to the increasing cases of chronic diseases as well as the increasing hospitalisation expenses. Home healthcare on the other hand offers affordable treatment options to the patient as compared to expensive hospital treatment which results in reducing the public expenditure on Healthcare services. 

 

Increasing focus on developing nations and rising adoption of specialty infusion systems to propel the market

Developing countries India, China, and Brazil provide massive growth opportunities for the key market players. The growth can be attributed due to the increasing cases of chronic diseases and infectious health ailments, rising investments in research and development activities, and diverse healthcare infrastructure. Apart from this, the development in healthcare infrastructure , affordable manufacturing of the products in developing nations  are anticipated to propel the market growth. On the other hand, the increasing adoption of various specialty infusion pumps across the world  as driven the market growth.

 

Key Market Challenges

High medicine cost and lack of wireless connectivity in hospitals to restrain the market growth

Some of the most common infusion errors are unit errors, miscalculations, multiples of ten errors, and push button mistakes. The lack of interoperability of smart infusion devices as well as hospital information systems in various hospitals owing to the lack of wireless connectivity and low hospital budgets are anticipated to hamper the overall market growth.

 

Market Segmentation

Type Insights

The tethered pumps segment is dominating the market with the largest market share over the forecast period

On the basis of type, the global insulin infusion pump market is segmented into patch, tethered. Among these, the tethered pumps segment is dominating the market with the largest market share over the forecast period. Tethered pumps come with flexible tubing between the cannula and the pump. The main reason behind the growth of the segment is its reliability and availability of various products across the market. The patch pump segment is witnessing the fastest market growth owing to its benefits like there is no tubing in patch pumps as well as its remote control feature acts as a glucose meter.

 

Product Insights

Medtronic’s MiniMed insulin pumps segment accounted the largest market share over the forecast period

On the basis of product, the global insulin infusion pump market is segmented into MiniMed, Accu-Check, Tandem, Omnipod, My Life Omnipod, Others. Among these, the Medtronic’s MiniMed insulin pumps segment accounted the largest market share over the forecast period due to the increasing rate of adoption as well as advancement in the field of technology. The growth of the segment is mainly attributed to the strong foothold and its strong regional presence and the launch of its MiniMed 760G system which is the first hybrid closed loop system of the world.

 

Accessories Insights

The insulin set insertion devices segment holds the largest market share over the forecast period

Based on the accessories, the global insulin infusion pump market is segmented into insulin reservoir or catridges, insulin set insertion devices, and battery. Among these, the insulin set insertion devices segment dominates the market with the largest market share over the forecast period. The main reason behind the growth is its usage such as in general infusion sets of insulin pumps are being changed after every two to three days and they are very expensive.

 

End Use Insights

The Hospitals and Clinics segment accounted the largest market share over the forecast period

On the basis of end use, the global insulin infusion pump market is segmented into hospitals and clinics, homecare, laboratories. Among these, the hospitals and clinics segment accounted the largest market share over the forecast period owing to the availability of skilled healthcare experts, increasing investment made by the governments, as well as increasing private sector funding in the healthcare sector.

 

Regional Analysis

North America is dominating the market with the largest market share over the forecast period

 

Global Insulin Infusion Pumps Market

Get more details on this report -

Request Free Sample PDF

North America dominates the market with the largest market share of 47.2% over the forecast period  due to the strong presence of the key market players. Apart from this, the rising prevalence of obesity, technological advancement, high treatment cost, product launches, and investment in research and development activities are anticipated to drive the market.

 

Asia Pacific, on the other hand is witnessing the fastest market growth  owing to increasing healthcare investment and strategic initiatives made by the government in spreading awareness about diabetes. Among all other countries, China is leading the market due to its economic growth and increasing diabetic population.

 

Recent Developments

  • In June 2022, Insulet Corporation has made an announcement about its investment of USD 200 million in opening its new manufacturing unit in Johor over the next 5 years.

 

  • In June 2022, Diabeloop has signed an agreement with the American Diabetes Association Scientific Session to establish clinical trials for the expansion of their cooperation.

 

List of Key Companies

  • Hoffman-La Roche Ltd.
  • Tandem Diabetic Care, Inc.
  • Medtronic plc
  • Sooil Development
  • Insulet Corporation
  • JingasuDelfu Co., Ltd.
  • Valeritas, Inc.
  • Ypsomed

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Insulin Infusion Pumps Market based on the below-mentioned segments:

 

Insulin Infusion Pumps Market, Product Analysis

  • MiniMed
  • Accu-Chek
  • Tandem
  • Omnipod
  • My Life Omnipod
  • Others

 

Insulin Infusion Pumps Market, Accessories Analysis

  • Insulin reservoir or catridges
  • Insulin set insertion devices
  • Battery

 

Insulin Infusion Pumps Market, Type Analysis

  • Patch Pumps
  • Tethered Pumps

 

Insulin Infusion Pumps Market, End Use Analysis

  • Hospitals and Clinics
  • Homecare
  • Laboratories

 

Insulin Infusion Pumps Market, Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. What is the market size of Insulin Infusion Pumps Market?
    The global Insulin Infusion Pumps Market is expected to grow from USD 4.2 Billion in 2021 to USD 7.9 Billion by 2030, at a CAGR of 8.5% during the forecast period 2022-2030.
  • 2. Who are the key market players of Insulin Infusion Pumps Market?
    Some of the key market players of Insulin Infusion Pumps Market are Medtronic plc, Tandem Diabetic Care, Inc., Hoffman-La Roche Ltd., Insulet Corporation.
  • 3. Which segment hold the largest market share?
    Hospitals and clinics segment hold the largest market share is going to continue its dominance.
  • 4. Which region is dominating the Insulin Infusion Pumps Market?
    North America is dominating the Insulin Infusion Pumps Market with the highest market share.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies